|
Filovirus Animal Non-Clinical Group (FANG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
The Filovirus Animal Non-Clinical Group (FANG) focuses on the advanced development of Filovirus medical countermeasures (MCM), both vaccines and therapeutics. The FANG focuses on the product development tools and other interagency product development issues relevant to FDA approval of filovirus MCM. A standing interagency working group, the Portfolio Advisory Committee, oversees the FANG. The FANG will develop strategies to address broadly applicable and interagency product development issues relevant to licensure of filovirus MCM. The FANG will develop consensus recommendations to facilitate standardization of reagents, methods, and procedures across multiple agencies and laboratories.
|
|
Fogarty HIV Research Training Program
|
Training Initiative
|
CDC
|
FIC, NIDA
|
The goal of the Fogarty HIV Research Training Program (AITRP) is to build multi-disciplinary bio-medical, behavioral, and social science research capacity for the prevention, care, and treatment of HIV/AIDS and HIV-related conditions in adults and children in low- and middle- income countries (LMIC). Research training will be provided to scientists at institutions in countries defined by the World Bank criteria as LMIC. In FY15, PEPFAR/CDCCOP funded one supplement to a parent AITRP award in Ukraine through SUNY Medical Center Downstate. Also, research training activities in Uganda continued to be supported in FY 15 through the FY2014 PEPFAR/CDC-COP funded supplement to the Fogarty HIV Research Training award at the University of California, Berkeley.
|
|
Forum on Regenerative Medicine
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDCR, NHLBI, NIAMS, NIBIB, NIDDK, NINDS
|
Six NIH institutes and FDA are participating in a multi-year National Academy of Medicine (NAM)-led activity entitled "Forum on Regenerative Medicine". The objective of the Forum is to engage key stakeholders of regenerative medicine in a dialogue about opportunities and challenges facing translation of regenerative medicine science and technologies to clinic. The setting of the NAM provides a neutral convening mechanism for interactions between academia, industry, government, regulators, patients’ organizations, foundations and others. In addition to science, ethical, legal and societal issues related to regenerative
medicine are discussed. In October 2016 the Forum supported a highly successful interdisciplinary workshop that examined the current state of science in regenerative medicine. Further activities are currently being planned.
|
|
Full-text health-related documents at NLM (includes HSTAT)
|
Resource Development
|
AHRQ, ATSDR, CDC, CMS, FDA, OSG, SAMHSA
|
NLM
|
The National Library of Medicine of the National Institutes of Health provides a free, web-based resource of full-text documents that provide information on health-care decision making.
|
|
Funding Opportunity Announcement Module (FOAM)
|
Resource Development
|
ACF
|
OD/OER, NHLBI
|
The Funding Opportunity Announcement Module (FOAM) allows NIH Institutes and Centers and HHS Operating Divisions to develop content for and perform the needed approvals to publish funding opportunity announcements. The system has a flexible configuration to meet all of the needs for HHS Operating Divisions. Furthermore, FOAM achieves economies of scale by preventing the need for individual agencies to develop duplicate systems at a cost much greater than that of developing a unified system.
|
|
Gene-Environment Interaction in Orofacial Clefting
|
Meeting/ Workshop
|
CDC
|
NIDCR, NIAAA, NICHD, NIDA, NIEHS
|
This workshop was held September 6-7, 2016, and brought together experts across multiple scientific disciplines to assess the current research into a role for gene-environment interactions in the etiology of orofacial clefting. At the conclusion of the workshop several strategies were put forward to speed the pace of discovery and reduce barriers to advancement in this field.
|
|
Genetic Studies in the National Birth Defects Prevention Study
|
Research Initiative
|
CDC
|
NHGRI
|
This study is a collaboration between CDC and NHGRI to carry out DNA sequencing and genotyping on samples collected as part of the National Birth Defects Prevention Study.
|
|
Global Environmental and Occupational Health (GEOHealth)
|
Research Initiative
|
CDC
|
FIC, NCI, NIEHS
|
FIC, NCI, NIEHS and NIOSH/CDC, Canada’s International Development Research Centre (IDRC), and the Global Alliance for Clean Cookstoves are supporting Global Environmental and Occupational Health (GEOHealth) Hubs, which are regional hubs based at low- or middle-income country (LMIC) institutions focused on collaborative research, data management, training, curriculum development and policy support around high-priority local, national and regional environmental and occupational health threats. The expectation is that GEOHealth Hubs will become the lead resources for environmental and occupational health, attract and retain the best talent in the region, and provide the scientific evidence for policy formulation. Together all regional hubs supported will form the GEOHealth Network, a platform for coordinated environmental and occupational health research and research training activities. FIC and its partners are supporting linked U2R and U01 awards to U.S. and LMIC institutions, respectively. All partners contribute funds to the program.
|
|
Global Health - Household Air Pollution Investigation Network (HAPIN)
|
Research Initiative
|
CDC
|
OD/DPCPSI, FIC, NCI, NHLBI, NICHD, NIEHS, OD/DPCPSI/OSC
|
The Household Air Pollution Investigation Network (HAPIN) is a large NIH initiative designed to tackle the challenge of reducing the burden of disease from household air pollution (HAP). Within HAPIN, an Implementation Science Network (ISN) was formed to advance the science of uptake and scale up of clean cooking technology in the developing world. The ISN steering committee is composed of HAP experts from across NIH and various government and non-government agencies.
|
|
Global Health Security Advisory Group (GHSAG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
NIAID, NINDS
|
The Global Health Security Advisory Group (GHSAG) is a committee composed of high-level representatives of the national health authorities for the G-8 block of countries. The GHSAG was formed to develop and implement concrete actions to improve global health security and serve as a network for rapid response to biological, chemical, radio-nuclear terrorism (CBRN) crises.
|